Cypress Capital Management (Wyoming)’s GSK GSK Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-440	Closed	-$22K	–	221
2019 Q2	$22K	Hold	440	–	–	0.03%	153
2019 Q1	$23K	Hold	440	–	–	0.03%	145
2018 Q4	$21K	Hold	440	–	–	0.04%	176
2018 Q3	$22K	Hold	440	–	–	0.02%	213
2018 Q2	$22K	Hold	440	–	–	0.02%	210
2018 Q1	$21K	Hold	440	–	–	0.02%	196
2017 Q4	$20K	Sell	440 -480	-52%	-$22.2K	0.02%	209
2017 Q3	$47K	Hold	920	–	–	0.06%	134
2017 Q2	$49.6K	Buy	920 +760	+475%	+$40.5K	0.06%	123
2017 Q1	$8.43K	Hold	160	–	–	0.01%	214
2016 Q4	$7.7K	Sell	160 -100	-38%	-$4.94K	0.01%	215
2016 Q3	$14K	Hold	260	–	–	0.02%	167
2016 Q2	$14.1K	Sell	260 -672	-72%	-$35.4K	0.02%	156
2016 Q1	$47.2K	Hold	932	–	–	0.06%	110
2015 Q4	$47K	Hold	932	–	–	0.06%	118
2015 Q3	$44.8K	Sell	932 -100	-10%	-$5.21K	0.06%	118
2015 Q2	$53.7K	Hold	1,032	–	–	0.06%	124
2015 Q1	$59.5K	Buy	1,032 +100	+11%	+$5.73K	0.07%	113
2014 Q4	$49.8K	Buy	+932	New	+$52.1K	0.06%	104

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s GSK Position: Q3 2019 in Review

Cypress Capital Management (Wyoming) sold out of GSK (GSK) in Q3 2019, closing a stake of 440 shares — an estimated $22K sold.

Cypress Capital Management (Wyoming) first reported a position in GSK in Q4 2014 and held it in 19 quarters. The position peaked at $59.5K in Q1 2015. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Cypress Capital Management (Wyoming) reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
Cypress Capital Management (Wyoming) sold 440 GSK shares in Q3 2019, an estimated $22K.
Cypress Capital Management (Wyoming) first reported a position in GSK in Q4 2014 and held it in 19 quarters.
Cypress Capital Management (Wyoming)'s GSK position peaked at $59.5K in Q1 2015.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2019, filed 12 Nov 2019.